CHRW

Over the past six months (April-October 2026), C.H. Robinson's stock experienced significant volatility, including an 8.0% single-day increase in April and another positive change in August. Key events included Q1 and Q2 2026 earnings releases, which showed better-than-expected revenue and EPS in Q2, and quarterly dividend payments. Analyst ratings varied, with Susquehanna issuing a "positive" rating and Weiss Ratings downgrading the stock. A major event was the October 5th announcement of the $5.8 billion acquisition of RXO, which caused a 9% stock drop and a negative outlook revision from S&P Global Ratings due to expected debt increase. By October 6th, CHRW shares had fallen 15.1% year-to-date, with notable insider selling.